Literature DB >> 15522650

RNA interference, DNA methylation, and gene silencing: a bright future for cancer therapy?

Charles Swanton1, Barbara Nicke, Julian Downward.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15522650     DOI： 10.1016/S1470-2045(04)01604-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

1.  Identification of aberrant promoter hypomethylation of HOXA10 in ovarian cancer.

Authors:  Wenjun Cheng; Yi Jiang; Cuixia Liu; Ouxi Shen; Weiwei Tang; Xinru Wang
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-12       Impact factor: 4.553

Review 2.  The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic.

Authors:  Samuel Broder
Journal:  Antiviral Res       Date:  2009-12-16       Impact factor: 5.970

3.  Gene silencing of heparanase results in suppression of invasion and migration of hepatoma cells.

Authors:  Weiwei Dong; Huixia Zhao; Caihong Zhang; Paili Geng; Qiuwen Li; Jianhua Zhu; Guanghui Li; Shufang Zhang; Ming Ye; Wenhua Xiao
Journal:  World J Surg Oncol       Date:  2014-04-04       Impact factor: 2.754

4.  Systemic Investigation of Promoter-wide Methylome and Genome Variations in Gout.

Authors:  Chia-Chun Tseng; Man Chun Wong; Wei-Ting Liao; Chung-Jen Chen; Su-Chen Lee; Jeng-Hsien Yen; Shun-Jen Chang
Journal:  Int J Mol Sci       Date:  2020-07-01       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.